Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28297074 | 0.85 | CYP1A2 (0.43) | CYP1A2MAPK1SMN1; SMN2NFKB1DPP7 | |
| SCHEMBL29085077 | 0.83 | SIGMAR1 (0.41) | LMNATSHRNFKB1PMP22GSTK1 | |
| SCHEMBL28131788 | 0.83 | ALDH1A1 (0.40) | CYP1A2MAPK1SMN1; SMN2LMNATSHR | |
| SCHEMBL28687392 | 0.83 | MAPT (0.49) | MAPK1FFAR1GPR84 | |
| SCHEMBL10448991 | 0.83 | MAPT (0.49) | MAPK1FFAR1GPR84 | |
| SCHEMBL22433662 | 0.81 | GPR84 (0.48) | MAPK1FFAR1GPR84 | |
| SCHEMBL4410674 | 0.79 | CYP1A2 (0.46) | CYP1A2MAPK1SMN1; SMN2LMNATSHR | |
| SCHEMBL14093946 | 0.79 | MAPT (0.41) | SMN1; SMN2LMNADPP7ALDH1A1 | |
| SCHEMBL22500187 | 0.79 | SIGMAR1 (0.48) | MAPK1ALDH1A1 | |
| Adipic Acid SCHEMBL31405497 | 0.77 | SIGMAR1 (0.41) | CYP1A2MAPK1SMN1; SMN2LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120308814-A1 | Method for Stabilizing Polyacrylate Pressure-Sensitive Adhesives in Admixture with Adhesive Resins | TESA SE (DE) | 2012-12-06 | — | — | US | disclosed |
| EP-1910462-A2 | STABILISED HDK SUSPENSIONS FOR REINFORCEMENT OF REACTIVE RESINS | Wacker Chemie AG (DE) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007012547-A2 | STABILISED HDK SUSPENSIONS FOR REINFORCEMENT OF REACTIVE RESINS | WACKER CHEMIE AG (DE) | 2007-02-01 | — | — | WO | disclosed |
| US-6013727-A | BLEND OF THERMOPLASTIC ENGINEERING RESIN AND A HALOGENATED COPOLYMER OF A C4 TO C7 ISOMONOOLEFIN AND A PARA-ALKYLSTYRENE WHICH CAN BE DYNAMICALLY VULCANIZED; IMPROVED PROPERTIES SUCH AS SOFTENING TEMPERATURE, AND RESISTANCE TO COMPRESSION SET | EXXON CHEMICAL PATENTS, INC. (US) | 2000-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120308814-A1 | Method for Stabilizing Polyacrylate Pressure-Sensitive Adhesives in Admixture with Adhesive Resins | TTPA, SORBS1, TXN | CYP1A2 3204/4885MAPK1 2174/4885SMN1; SMN2 3182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.